Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-09

Clinical Trial Update: Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Gemcitabine with Trastuzumab and Gemcitabine with Cisplatin/Trastuzumab in metastatic breast cancer has completed with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Gemcitabine (Gemcitabine)
  • Trastuzumab (trastuzumab)

Snippet

Sponsor: Kari Kendra | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-11-09